ERC Advanced Grant for prof. Johan Neyts

Image: © University of Melbourne – Josefina Vargas
Professor Johan Neyts of the KU Leuven in Belgium was awarded a prestigious European Research Council (ERC) Advanced Grant for his groundbreaking project, titled ANTIVIRMAP (Discovery of druggable antiviral targets and replication mechanisms across viral families through chemical probing).
“Viruses, known or yet to emerge, will always remain a health threat,” says Johan Neyts. “Vaccines prevent infections and antiviral drugs are needed for treatment. For most viral infections, however, such drugs do not exist nor are even on the horizon. There is even little knowledge about the weak spots of most viruses and how to block their replication. With ANTIVIRMAP I want to fundamentally revolutionize the discovery of novel targets that can be exploited to develop antiviral drugs. The rabies virus is one of the viruses I will study. Each year at least sixty thousand people die an agonizing death because of rabies. Once symptoms appear, mortality is 100% certain. This is unacceptable; I want to act.”
ERC Advanced Grants are awarded to individual researchers for a five-year period and are awarded to fundamental, ground-breaking research on the basis of one single criterion: excellence.










